VEGFA and age-related macular degeneration: Without anti-VEGF drug therapy, the reduction would be much greater, because, since the introduction of intravitreally injected anti-VEGF in 2006, the incidence of legal blindness from AMD has already fallen to half the previous baseline incidence rate.[57] The screening program reduced the blindness rate by more than did additional intake of supplements.